Italia markets closed

TEVA Jul 2024 15.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,04000,0000 (0,00%)
In data: 10:34AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0400
Aperto0,0500
Denaro0,0100
Domanda0,2000
Prezzo d'esercizio15,00
Scadenza2024-07-05
Min-Max giorno0,0400 - 0,0500
Contratto - Min-MaxN/D
Volume62
Open Interest35
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.